259 related articles for article (PubMed ID: 37402929)
1. Risk factors for cardiovascular disease in primary Sjögren's syndrome (pSS): a 20-year follow-up study.
Santos CS; Salgueiro RR; Morales CM; Castro CÁ; Álvarez ED
Clin Rheumatol; 2023 Nov; 42(11):3021-3031. PubMed ID: 37402929
[TBL] [Abstract][Full Text] [Related]
2. Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution.
Quartuccio L; Baldini C; Bartoloni E; Priori R; Carubbi F; Corazza L; Alunno A; Colafrancesco S; Luciano N; Giacomelli R; Gerli R; Valesini G; Bombardieri S; De Vita S
Autoimmun Rev; 2015 Nov; 14(11):1019-22. PubMed ID: 26162302
[TBL] [Abstract][Full Text] [Related]
3. Association between comorbidities and extraglandular manifestations in primary Sjögren's syndrome: a multicenter cross-sectional study.
Zhang Y; Li M; Zhang L; Li Q; Yang P; Kong X; Duan X; Zhang M; Li X; Wang Y; Xu J; Wang Y; Hsieh E; Zhao J; Xu D; Zhao Y; Zeng X
Clin Rheumatol; 2020 Sep; 39(9):2677-2688. PubMed ID: 32146615
[TBL] [Abstract][Full Text] [Related]
4. Primary Sjögren's syndrome independently promotes premature subclinical atherosclerosis.
Zehrfeld N; Abelmann M; Benz S; Zippel CL; Beider S; Kramer E; Seeliger T; Sogkas G; Gödecke V; Ahrenstorf G; Armbruster FP; Skripuletz T; Witte T; Derda AA; Sonnenschein K; Ernst D
RMD Open; 2024 Apr; 10(2):. PubMed ID: 38663882
[TBL] [Abstract][Full Text] [Related]
5. Systemic phenotype related to primary Sjögren's syndrome in 279 patients carrying isolated anti-La/SSB antibodies.
Acar-Denizli N; Horváth IF; Mandl T; Priori R; Vissink A; Hernandez-Molina G; Armagan B; Praprotnik S; Sebastian A; Bartoloni E; Rischmueller M; Pasoto SG; Nordmark G; Nakamura H; Fernandes Moça Trevisani V; Retamozo S; Carsons SE; Maure-Noia B; Sánchez-Berná I; López-Dupla M; Fonseca-Aizpuru E; Melchor Díaz S; Vázquez M; Díaz Cuiza PE; de Miguel Campo B; Ng WF; Rasmussen A; Dong X; Li X; Baldini C; Seror R; Gottenberg JE; Kruize AA; Sandhya P; Gandolfo S; Kwok SK; Kvarnstrom M; Solans R; Sene D; Suzuki Y; Isenberg DA; Valim V; Hofauer B; Giacomelli R; Devauchelle-Pensec V; Atzeni F; Gheita TA; Morel J; Izzo R; Kalyoncu U; Szántó A; Olsson P; Bootsma H; Ramos-Casals M; Kostov B; Brito-Zerón P;
Clin Exp Rheumatol; 2020; 38 Suppl 126(4):85-94. PubMed ID: 33095152
[TBL] [Abstract][Full Text] [Related]
6. Risk of Cardiovascular Involvement in Patients with Primary Sjögren's Syndrome: a large-scale cross-sectional cohort study.
Cai X; Luo J; Wei T; Qin W; Wang X; Li X
Acta Reumatol Port; 2019; 44(1):71-77. PubMed ID: 31249278
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of serum metabolic alterations in primary Sjögren's syndrome: influence on clinical and immunological expression.
Ramos-Casals M; Brito-Zerón P; Sisó A; Vargas A; Ros E; Bove A; Belenguer R; Plaza J; Benavent J; Font J
J Rheumatol; 2007 Apr; 34(4):754-61. PubMed ID: 17309127
[TBL] [Abstract][Full Text] [Related]
8. Clinical, immunological, and immunogenetic aspects of autoantibody production against Ro/SSA, La/SSB and their linear epitopes in primary Sjögren's syndrome (pSS): a European multicentre study.
Tzioufas AG; Wassmuth R; Dafni UG; Guialis A; Haga HJ; Isenberg DA; Jonsson R; Kalden JR; Kiener H; Sakarellos C; Smolen JS; Sutcliffe N; Vitali C; Yiannaki E; Moutsopoulos HM
Ann Rheum Dis; 2002 May; 61(5):398-404. PubMed ID: 11959762
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up in primary Sjögren's syndrome reveals differences in clinical presentation between female and male patients.
Ramírez Sepúlveda JI; Kvarnström M; Eriksson P; Mandl T; Norheim KB; Johnsen SJ; Hammenfors D; Jonsson MV; Skarstein K; Brun JG; ; Rönnblom L; Forsblad-d'Elia H; Magnusson Bucher S; Baecklund E; Theander E; Omdal R; Jonsson R; Nordmark G; Wahren-Herlenius M
Biol Sex Differ; 2017 Aug; 8(1):25. PubMed ID: 28789696
[TBL] [Abstract][Full Text] [Related]
10. Concomitant Ro/SSA and La/SSB antibodies are biomarkers for the risk of venous thromboembolism and cerebral infarction in primary Sjögren's syndrome.
Mofors J; Holmqvist M; Westermark L; Björk A; Kvarnström M; Forsblad-d'Elia H; Magnusson Bucher S; Eriksson P; Theander E; Mandl T; Wahren-Herlenius M; Nordmark G
J Intern Med; 2019 Oct; 286(4):458-468. PubMed ID: 31127862
[TBL] [Abstract][Full Text] [Related]
11. Development of new extra-glandular manifestations or associated auto-immune diseases after establishing the diagnosis of primary Sjögren's syndrome : A long-term study of the Antonius Nieuwegein Sjögren (ANS) cohort.
Ter Borg EJ; Kelder JC
Rheumatol Int; 2017 Jul; 37(7):1153-1158. PubMed ID: 28424927
[TBL] [Abstract][Full Text] [Related]
12. Significance of anti-La/SSB antibodies in primary Sjögren's syndrome patients with combined positivity for anti-Ro/SSA and salivary gland biopsy.
Cafaro G; Perricone C; Baldini C; Quartuccio L; Priori R; Carubbi F; Ferro F; Colafrancesco S; Bini V; De Vita S; Giacomelli R; Gerli R; Bartoloni E;
Clin Exp Rheumatol; 2020; 38 Suppl 126(4):53-56. PubMed ID: 33095137
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary arterial hypertension: a rare complication of primary Sjögren syndrome: report of 9 new cases and review of the literature.
Launay D; Hachulla E; Hatron PY; Jais X; Simonneau G; Humbert M
Medicine (Baltimore); 2007 Sep; 86(5):299-315. PubMed ID: 17873760
[TBL] [Abstract][Full Text] [Related]
14. Sjögren's syndrome with and without neurological involvement.
Seeliger T; Kramer E; Konen FF; Zehrfeld N; Beider S; Prenzler NK; Gödecke V; Witte T; Skripuletz T; Ernst D
J Neurol; 2023 Jun; 270(6):2987-2996. PubMed ID: 36802030
[TBL] [Abstract][Full Text] [Related]
15. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
[TBL] [Abstract][Full Text] [Related]
16. Dysregulated serum lipid profile is associated with inflammation and disease activity in primary Sjögren's syndrome: a retrospective study in China.
Yang L; Liang Y; Pu J; Cai L; Gao R; Han F; Chang K; Pan S; Wu Z; Zhang Y; Wang Y; Song J; Wu H; Tang J; Wang X
Immunol Lett; 2024 Jun; 267():106865. PubMed ID: 38705483
[TBL] [Abstract][Full Text] [Related]
17. Clinical and laboratory profiles of primary Sjogren's syndrome in a Chinese population: A retrospective analysis of 315 patients.
Li X; Xu B; Ma Y; Li X; Cheng Q; Wang X; Wang G; Qian L; Wei L
Int J Rheum Dis; 2015 May; 18(4):439-46. PubMed ID: 25925697
[TBL] [Abstract][Full Text] [Related]
18. Lung involvement in patients with primary Sjögren's syndrome: what are the predictors?
Yazisiz V; Arslan G; Ozbudak IH; Turker S; Erbasan F; Avci AB; Ozbudak O; Terzioglu E
Rheumatol Int; 2010 Aug; 30(10):1317-24. PubMed ID: 19844720
[TBL] [Abstract][Full Text] [Related]
19. Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome?
Manthorpe R; Benoni C; Jacobsson L; Kirtava Z; Larsson A; Liedholm R; Nyhagen C; Tabery H; Theander E
Ann Rheum Dis; 2000 Jan; 59(1):54-60. PubMed ID: 10627428
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population-based multicentre cohort study.
Bartoloni E; Baldini C; Schillaci G; Quartuccio L; Priori R; Carubbi F; Bini V; Alunno A; Bombardieri S; De Vita S; Valesini G; Giacomelli R; Gerli R
J Intern Med; 2015 Aug; 278(2):185-92. PubMed ID: 25582881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
